Serological analysis of anti-K and anti-Wra detected in patient treated with daratumumab: a case report

Journal Title: Chinese Journal of Blood Transfusion - Year 2024, Vol 37, Issue 4

Abstract

Objective To investigate the reasonable serological detection method by analyzing the characteristics of anti-K and anti-Wra from a patient who received treatment with daratumumab. Methods Unexpected antibody screening and identification were performed by saline method, polybrene, cardioagglutinin, dithiothreitol (DTT) treatment, trypsin treatment and papain treatment in the patient's plasma and acid elution solution. Heat elution test was detected after absorbing patient serum with K antigen negative red blood cells. The characteristics of antibodies were analyzed and their titer was continuously detected. Cross matching was performed after excluding interference of daratumumab. Results Anti-K and anti-Wra were detected in saline and polybrene in the patient's plasma. The patient's elution solution contained daratumumab. DTT or trypsin treatment excluded interference of daratumumab but papain treatment did not. DTT treatment destroyed K antigen and missed the detection of IgG antibodies in the Kell system. Trypsin treatment did not affect K antigen and can detect IgG antibodies of Kell system(anti-k)in the serum of the patient treated with daratumumab. Anti K was IgM and the titer was 4 by saline method and it decreased to no agglutination in room temperature after 39 days. Anti-Wra was IgG and the titer by polybrene method was 4, and it decreased to 1 after 39 days. After 76 days, neither anti-K nor anti-Wra could be detected. Transfusions of K and Wra antigen negative red blood cells were safe and effective. Conclusion DTT treatment can exclude interference of daratumumab, but attention should be paid to missed detection of anti-K. To avoid interference of daratumumab and identify unexpected antibody, multiple methods such as DTT treatment, polybrene and trypsin treatment in combination are recommended.

Authors and Affiliations

Xian HUANG, Ying ZHAO, Tongtong LI, Yang YANG, Lei MA, Jinhui JIE, Jinghui ZHONG

Keywords

Related Articles

Evaluation and analysis of bleeding risk of anticoagulation therapy in severe non-ICU patients with COVID-19 based on heparinase-modified TEG

Objective To investigate the clinical application of heparinase-modified TEG (hmTEG) in evaluating coagulation status and monitoring anticoagulant therapy in severe non-ICU patients with COVID-19. Methods The clinical da...

Secondary herpes zoster wound cured by allogeneic platelet-rich plasma: a case report

Objective To investigate the feasibility of allogeneic platelet-rich plasma (PRP) for the treatment of herpes zoster wounds secondary to systemic lupus erythematosus (SLE), especially large ulcer wounds. Methods The trea...

Sequential generation of anti-M and anti-Jka leads to two delayed hemolytic transfusion reactions and corresponding strategies

Objective To make transfusion management strategies for patients with history of blood transfusion and/or pregnancy by following up a patient with delayed hemolytic transfusion reactions(DHTR) caused by unexpected antibo...

Current status of positive psychological qualities among voluntary blood donors in college

Objective To explore the current status of positive psychological qualities among college students who had participated in voluntary blood donation in Changsha area, so as to demonstrate that scientific blood donation ca...

Polymorphism study of HLA-A, B, DRB1 alleles in patients with chronic renal failure, in Shandong Peninsula

Objective To investigate the association between HLA-A, B, DRB1 alleles and chronic renal failure (CRF) in Han population of Shandong Peninsula. Methods Sequence specific oligonucleotide probe-polymerase chain reaction (...

Download PDF file
  • EP ID EP738806
  • DOI 10.13303/j.cjbt.issn.1004-549x.2024.04.016
  • Views 9
  • Downloads 0

How To Cite

Xian HUANG, Ying ZHAO, Tongtong LI, Yang YANG, Lei MA, Jinhui JIE, Jinghui ZHONG (2024). Serological analysis of anti-K and anti-Wra detected in patient treated with daratumumab: a case report. Chinese Journal of Blood Transfusion, 37(4), -. https://europub.co.uk/articles/-A-738806